SCHEMBL19848435

SCHEMBL19848435

Cc1cc2nnn(-c3ccncc3)c2cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NPC1 O15118 3/20 0.41
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MGAM O43451 6/20 0.41
AMY1A P0DUB6 6/20 0.41
GAA P10253 6/20 0.41
SI P14410 6/20 0.41
MGAM2 Q2M2H8 6/20 0.41
GPR55 Q9Y2T6 1/20 0.40
RAB9A P51151 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10452441 0.84 NPC1 (0.58) ALDH1A1NPSR1NPC1KDM4EL3MBTL1
SCHEMBL19911495 0.81 ALDH1A1 (0.45) ALDH1A1NPC1KDM4EL3MBTL1RAB9A
SCHEMBL19848242 0.81 ALDH1A1 (0.49) ALDH1A1NPC1KDM4EL3MBTL1GAA
SCHEMBL19911580 0.75 NPC1 (0.73) ALDH1A1NPC1KDM4EL3MBTL1RAB9A
SCHEMBL19911611 0.75 ALDH1A1 (0.49) ALDH1A1NPC1KDM4EL3MBTL1MAPK9
SCHEMBL19848336 0.75 NPC1 (0.55) ALDH1A1NPC1KDM4EL3MBTL1GAA
SCHEMBL19848740 0.75 ALDH1A1 (0.45) ALDH1A1NPC1KDM4EL3MBTL1MAPK9
SCHEMBL19911524 0.74 HDAC3 (0.45) ALDH1A1NPSR1L3MBTL1GAARAB9A
SCHEMBL19848195 0.74 ALDH1A1 (0.45) ALDH1A1NPSR1NPC1KDM4EL3MBTL1
SCHEMBL19848168 0.73 ALDH1A1 (0.64) ALDH1A1NPC1KDM4EL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed
EP-3279997-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY Asahi Kasei Kabushiki Kaisha (JP) 2018-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery BPTF, BRD4, KCNN2 ALDH1A1 3497/4885NPSR1 3412/4885NPC1 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.